These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 32174755)
1. Update on systemic therapy for advanced soft-tissue sarcoma. Smrke A; Wang Y; Simmons C Curr Oncol; 2020 Feb; 27(Suppl 1):25-33. PubMed ID: 32174755 [TBL] [Abstract][Full Text] [Related]
2. Potential combination chemotherapy approaches for advanced adult-type soft-tissue sarcoma. Kopp HG; Patel S; Brücher B; Hartmann JT Am J Clin Dermatol; 2008; 9(4):207-17. PubMed ID: 18572972 [TBL] [Abstract][Full Text] [Related]
3. Clinical Outcome of Systemic Treatment for Advanced Soft Tissue Sarcoma: Real-Life Perspective in Japan. Nakamura T; Asanuma K; Hagi T; Sudo A Drug Des Devel Ther; 2020; 14():4215-4220. PubMed ID: 33116409 [TBL] [Abstract][Full Text] [Related]
4. Advanced soft-tissue sarcoma in elderly patients: patterns of care and survival. Garbay D; Maki RG; Blay JY; Isambert N; Piperno Neumann S; Blay C; Zanardi E; Boudou-Rouquette P; Bozec L; Duffaud F; Bertucci F; Italiano A Ann Oncol; 2013 Jul; 24(7):1924-1930. PubMed ID: 23493135 [TBL] [Abstract][Full Text] [Related]
5. First-line anthracycline-based chemotherapy for angiosarcoma and other soft tissue sarcoma subtypes: pooled analysis of eleven European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group trials. Young RJ; Natukunda A; Litière S; Woll PJ; Wardelmann E; van der Graaf WT Eur J Cancer; 2014 Dec; 50(18):3178-86. PubMed ID: 25459395 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG). Sleijfer S; Ouali M; van Glabbeke M; Krarup-Hansen A; Rodenhuis S; Le Cesne A; Hogendoorn PC; Verweij J; Blay JY Eur J Cancer; 2010 Jan; 46(1):72-83. PubMed ID: 19853437 [TBL] [Abstract][Full Text] [Related]
7. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity. Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015 [TBL] [Abstract][Full Text] [Related]
8. Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective. Bae S; Brnabic A; Crowe P; Carey-Smith R; Andelkovic V; Singhal N; Stalley P; Yip D; Desai J Asia Pac J Clin Oncol; 2022 Dec; 18(6):605-613. PubMed ID: 35098667 [TBL] [Abstract][Full Text] [Related]
9. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG). Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710 [TBL] [Abstract][Full Text] [Related]
10. Phase II study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Palumbo R; Palmeri S; Antimi M; Gatti C; Raffo P; Villani G; Toma S Ann Oncol; 1997 Nov; 8(11):1159-62. PubMed ID: 9426338 [TBL] [Abstract][Full Text] [Related]
11. Absence of progression, not extent of tumour shrinkage, defines prognosis in soft-tissue sarcoma - An analysis of the EORTC 62012 study of the EORTC STBSG. Grünwald V; Litière S; Young R; Messiou C; Lia M; Wardelmann E; van der Graaf W; Gronchi A; Judson I; Eur J Cancer; 2016 Sep; 64():44-51. PubMed ID: 27323349 [TBL] [Abstract][Full Text] [Related]
12. European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Experience with Advanced/Metastatic Epithelioid Sarcoma Patients Treated in Prospective Trials: Clinical Profile and Response to Systemic Therapy. Touati N; Schöffski P; Litière S; Judson I; Sleijfer S; van der Graaf WT; Italiano A; Isambert N; Gil T; Blay JY; Stark D; Brodowicz T; Marréaud S; Gronchi A Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):448-454. PubMed ID: 29550245 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma. Chugh R; Dunn R; Zalupski MM; Biermann JS; Sondak VK; Mace JR; Leu KM; Chandler WF; Baker LH J Clin Oncol; 2005 May; 23(15):3597-604. PubMed ID: 15908670 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy - a retrospective study including 32 patients. Schuler MK; Gerdes S; West A; Richter S; Busemann C; Hentschel L; Lenz F; Kopp HG; Ehninger G; Reichardt P; Pink D BMC Cancer; 2016 Aug; 16():619. PubMed ID: 27507014 [TBL] [Abstract][Full Text] [Related]
15. Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials. Younger E; Litière S; Le Cesne A; Mir O; Gelderblom H; Italiano A; Marreaud S; Jones RL; Gronchi A; van der Graaf WTA Oncologist; 2018 Oct; 23(10):1250-1259. PubMed ID: 29650688 [TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. In GK; Hu JS; Tseng WW Ther Adv Med Oncol; 2017 Aug; 9(8):533-550. PubMed ID: 28794805 [TBL] [Abstract][Full Text] [Related]
17. Current trials and new aspects in soft tissue sarcoma of adults. Issels RD; Schlemmer M Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S4-8. PubMed ID: 12042982 [TBL] [Abstract][Full Text] [Related]
18. Multi-agent chemotherapy in advanced soft tissue sarcoma (STS) - A systematic review and meta-analysis. Zer A; Prince RM; Amir E; Abdul Razak AR Cancer Treat Rev; 2018 Feb; 63():71-78. PubMed ID: 29253836 [TBL] [Abstract][Full Text] [Related]
19. Molecular targets and novel therapeutic avenues in soft-tissue sarcoma. Elkrief A; Alcindor T Curr Oncol; 2020 Feb; 27(Suppl 1):34-40. PubMed ID: 32174756 [TBL] [Abstract][Full Text] [Related]
20. Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy. Charlson J Curr Treat Options Oncol; 2018 Oct; 19(12):65. PubMed ID: 30361919 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]